🔎 Trials Near Me

Gara Jalqabaatti › Dhukkuba Kroonii › Pennsylvania

Qorannoo klinikaalii Dhukkuba Kroonii Pennsylvania keessatti

Qorannoo 23 Dhukkuba Kroonii f Pennsylvania keessatti hirmaatuu jiru.

Magaalota Pennsylvania keessatti

Takkalaa qorannoo (Ingiliffa)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • UPMC Hillman Cancer Center, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Penn State University Milton S. Hershey Medical Center ( Site 5102), Hershey
  • Thomas Jefferson University Hospital ( Site 5133), Philadelphia
  • Frontier Clinical Research, LLC ( Site 5098), Uniontown
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548542

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05923073

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Frontier Clinical Research, Uniontown
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Susquehanna Research Group, Harrisburg
  • Penn State Milton S Hershey Medical Ctr, Hershey
  • University of Pennsylvania, Philadelphia
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Penn State Milton S. Hershey Medical Center-Site Number: 8400066, Hershey
  • University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
  • The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
  • The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Children's Hospital of Philadelphia (CHOP), Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 19 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT04844606

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • Allegheny Health Network, Wexford
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06045754

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05509777

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

  • Children's Hospital of Philadelphia - Main /ID# 262197, Philadelphia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Penn State Health Milton South Hershey Medical Center, Hershey
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Children's Hospital of Philadelphia, Philadelphia
  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT05781152

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Children's Hospital of Pittsburgh, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Susquehanna Research Group, LLC, Harrisburg
  • UPMC, Pittsburgh
  • Frontier Clinical Research, LLC, Uniontown
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT06456593

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

  • University of Pittsburgh Medical Center, Children's Hospital, Pittsburgh
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT07198113

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400009, Harrisburg
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06958536

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Namoota walitti qabaa jiraQorannoo ilaalaa
2 Months – 60 Years · Saalaa hunda · Haaromfame 13-Ama-2026 · NCT04528355

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 2
2 Months – 55 Years · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT01962415

Autologous Stem Cell Transplantation for Crohn's Disease

  • UPMC Prebyterian- Adult Gastroenterology, Pittsburgh
  • Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 10 hanga 60 · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT00692939

Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial

  • Children's Hospital of Philadelphia, Philadelphia
Namoota walitti qabaa jira
Umuriin 8 hanga 21 · Saalaa hunda · Haaromfame 12-Wax-2025 · NCT06216899

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.